Personalised Medicine

An interview with Bjorg K. Hunter, Device Engineering Manager from GSK ahead of Pre-Filled Syringes Europe 2018

20 November 2017 | By SMi Group

A debate on the impact of PFS regulation at Pre-Filled Syringes 2018...

Metabolism can be used to subtype hepatoblastoma

18 September 2017 | By Dr Zara Kassam (Drug Target Review)

Scientists have identified new biomarkers that could help more accurately classify the two main subtypes of hepatoblastoma...

Therapy proves effective in subgroup of COPD patients

12 September 2017 | By Dr Zara Kassam (Drug Target Review)

An antibody treatment has been found to reduce the rate of flare-ups by nearly 20 percent in patients with a subgroup of treatment-resistant COPD...

From cancer evolution to personalised therapies

14 August 2017 | By Dr Zara Kassam (Drug Target Review)

A research team have studied how alterations in a tumour depend on each other and how these dependencies determine cancer evolution...

Artificial Medical Intelligence to introduce medical record tech

19 June 2017 | By Niamh Marriott (Drug Target Review)

AMI has released the full version of HCC Coding as part of the EMscribe suite of tools in support of medical records processing and abstraction.

Arming T-cells to channel aggression against cancer

9 June 2017 | By Drug Target Review

Scientists have armed immune cells with a new surface molecule that causes them to respond aggressively when they encounter a protein that tumours actually use to camouflage themselves from the immune system. Researchers from the Helmholtz Zentrum München and various partners introduced the method in ‘Cancer Research’.

SOPHiA artificial intelligence empowers liquid biopsies to fight cancer

8 June 2017 | By Niamh Marriott (Drug Target Review)

Sophia Genetics injects artificial intelligence in liquid biopsies to accelerate early detection of cancer and monitor treatments’ effectiveness.

Queen’s researchers breakthrough discovery in fight against bowel cancer

1 June 2017 | By Niamh Marriott (Drug Target Review)

New research led by Queen’s University Belfast has discovered how a genomic approach to understanding bowel cancer could improve the prognosis and quality of life for patients.

Healing wounds with cell therapy

31 May 2017 | By Niamh Marriott (Drug Target Review)

An experimental treatment in mice allows the reprogramming of blood cells in order to promote the healing process of cutaneous wounds...

Removing old cells could extend joint health & stop osteoarthritis

27 April 2017 | By Niamh Marriott (Drug Target Review)

In a preclinical study in mice and human cells, researchers report that selectively removing old or 'senescent' cells from joints could stop and even reverse the progression of osteoarthritis.

Diagnosing cancer: new process for identifying biomarkers established

7 April 2017 | By Niamh Marriott (Drug Target Review)

Scientists have established a process for identifying biomarkers for the diagnosis of different types of cancer.

£10 million pancreatic cancer research fund for precision medicine

24 March 2017 | By Niamh Marriott (Drug Target Review)

The development of new treatments for pancreatic cancer is set to be transformed by a network of clinical trials, aiming to find the right trial for the right patient, after a £10 million investment from Cancer Research UK.

IDEA Bio-Medical Ltd.

New tool developed to help avoid adverse drug reactions

22 February 2017 | By Niamh Marriott (Drug Target Review)

Medicines are an important part of treating and preventing disease in adults and children.  The ideal medicine would have no side effects or adverse drug reactions (ADRs) as they are also called, but the reality is all medicines can cause unwanted effects, in some people.

AstraZeneca provide insight into biomarkers and personalised treatment at Asthma & COPD 2017

16 January 2017 | By SMi Group

SMi’s 13th annual Asthma & COPD conference returns to London on the 29 and 30 March 2017...